AI assistant
Sending…
HEALTHEQUITY, INC. — Director's Dealing 2018
Mar 29, 2018
30722_dirs_2018-03-29_91f90327-740a-4544-96fd-d61bb694afcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2018-03-27
Reporting Person: Otten William Robert (Executive VP of Sales)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-27 | Common Stock | A | 3781 | — | Acquired | 13781 | Direct |
| 2018-03-27 | Common Stock | F | 182 | $63.50 | Disposed | 13599 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $51.44 | 2027-06-21 | Common Stock (43000) | 43000 | Direct |
Footnotes
F1: Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 946 shares on March 27, 2019, and in three equal installments of 945 shares on March 27, 2020, 2021 and 2022.
F2: The option becomes exercisable in four equal annual installments on June 21, 2018, 2019, 2021, and 2022.
More from HEALTHEQUITY, INC.
Interim / Quarterly Report
2026
May 28
Earnings Release
2026
May 28
Annual Report
2026
May 13
Board/Management Information
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Annual Report
2026
Mar 17